Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human, Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults

NCT07357909 is registered in ClinicalTrials.gov with Yayasan Inovasi Molekuler Indonesia (Indonesia Molecular Innovation Foundation) as lead sponsor.

NCT NCT07357909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07357909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human, Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Lead sponsor
Yayasan Inovasi Molekuler Indonesia (Indonesia Molecular Innovation Foundation)
Phase
Phase 1
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer